Episode Details
Back to Episodes
Celiac Drug That Targets the Immune System Shows Promise
Description
A new study that approaches treating celiac disease by using nanoparticles to program the immune system to tolerate gluten showed promise in early results.
The study concluded that the drug, TAK-101, prevented gluten from triggering an immune reaction in those who have celiac disease. The results were published in the journal Gastroenterology.
Full Study here: https://www.gastrojournal.org/article/S0016-5085(21)00521-7/pdf?referrer=https%3A%2F%2Fwww.gastrojournal.org%2F
I would love to hear from you! Leave your messages for Andrea at contact@baltimoreglutenfree.com and check out www.baltimoreglutenfree.com
Gluten Free College 101
Website: www.glutenfreecollege.com
Facebook: http://www.Facebook.com/Glutenfreecollege
Hosted on Acast. See acast.com/privacy for more information.